HomeCompareSPQ vs JNJ

SPQ vs JNJ: Dividend Comparison 2026

SPQ yields 17.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPQ wins by $42.9K in total portfolio value
10 years
SPQ
SPQ
● Live price
17.60%
Share price
$25.84
Annual div
$4.55
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.9K
Annual income
$5,169.10
Full SPQ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPQ vs JNJ

📍 SPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPQ
Annual income on $10K today (after 15% tax)
$1,495.87/yr
After 10yr DRIP, annual income (after tax)
$4,393.74/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SPQ beats the other by $3,690.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPQ + JNJ for your $10,000?

SPQ: 50%JNJ: 50%
100% JNJ50/50100% SPQ
Portfolio after 10yr
$41.5K
Annual income
$2,998.44/yr
Blended yield
7.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPQ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPQ buys
0
JNJ buys
0
No recent congressional trades found for SPQ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPQJNJ
Forward yield17.60%3.36%
Annual dividend / share$4.55$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$62.9K$20.0K
Annual income after 10y$5,169.10$827.78
Total dividends collected$33.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPQ vs JNJ ($10,000, DRIP)

YearSPQ PortfolioSPQ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,460$1,759.85$10,676$355.77+$1.8KSPQ
2$15,381$2,049.29$11,407$389.39+$4.0KSPQ
3$18,822$2,364.29$12,198$426.53+$6.6KSPQ
4$22,844$2,703.94$13,056$467.62+$9.8KSPQ
5$27,510$3,066.96$13,987$513.12+$13.5KSPQ
6$32,887$3,451.79$14,998$563.56+$17.9KSPQ
7$39,046$3,856.56$16,098$619.52+$22.9KSPQ
8$46,058$4,279.22$17,295$681.69+$28.8KSPQ
9$54,000$4,717.52$18,599$750.82+$35.4KSPQ
10$62,949$5,169.10$20,022$827.78+$42.9KSPQ

SPQ vs JNJ: Complete Analysis 2026

SPQStock

The Simplify US Equity PLUS QIS ETF (SPQ) seeks to achieve long-term capital appreciation by overlaying a diversified basket of Quantitative Investment Strategies (QIS) on top of a core US equity exposure. The goal of the 100% equity + 50% QIS portfolio is to enhance both absolute and risk-adjusted returns of a core equity investment. The fund is also a simple way to gain exposure to an alternative return source without reducing equity exposure.

Full SPQ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPQ vs SCHDSPQ vs JEPISPQ vs OSPQ vs KOSPQ vs MAINSPQ vs ABBVSPQ vs MRKSPQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.